RARE: Ultragenyx Pharmaceutical Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,271.76
Enterprise Value ($M) 3,974.71
Book Value ($M) 353.83
Book Value / Share 3.83
Price / Book 9.25
NCAV ($M) -424.04
NCAV / Share -4.58
Price / NCAV -7.72

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -0.44
Return on Equity (ROE) -2.07

Liquidity (mrq)
Quick Ratio 2.24
Current Ratio 2.37

Balance Sheet (mrq) ($M)
Current Assets 817.12
Assets 1,503.46
Liabilities 1,241.16
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 560.23
Operating Income -535.97
Net Income -569.18
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -414.19
Cash from Investing -17.77
Cash from Financing 399.24

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Sands Capital Management, Llc 4.70 4.37
02-10 13G/A Wellington Management Group Llp 2.70 -44.34
11-14 13G/A Rtw Investments, Lp 2.10 -71.42

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-03 91,208 524,962 17.37
2025-04-02 52,007 455,373 11.42
2025-04-01 136,351 787,819 17.31
2025-03-31 138,748 692,120 20.05

(click for more detail)

Similar Companies
QDEL – QuidelOrtho Corporation QNCX – Quince Therapeutics, Inc.
QURE – uniQure N.V. RDUS – Radius Recycling, Inc.
REGN – Regeneron Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io